Phase 1/2 Study of INCAGN01876 - An Anti-Glucocorticoid-Induced Tumor Necrosis Factor Receptor Agonist Monoclonal Antibody, Plus Immunotherapy for Advanced Cancers
Favorite
Share
More Options
12

Open in WPS to view all 12 pages
This document is user-generated content (UGC). WPS Office is not responsible for its accuracy or copyright. If you believe this content violates your rights, please use the button.
